Speaker Profile
Tak Wing Lau

Tak Wing Lau MBBS, FRCS, FHKCOS, FHKAM

Orthopedics, Trauma
Hong Kong, Hongkong, Hong Kong

Connect with the speaker?

Dr Lau, Tak-wing joined the Department of Orthopaedics and Traumatology in Queen Mary Hospital, Hong Kong in 1995 after he graduated from the University of Hong Kong. Since then, he has been working for the development of his interest in trauma surgeries and fracture management, especially in fragility fractures management. He received his orthopaedic specialist fellowship in 2005. He is also the chairperson of the AO trauma Asia Pacific Hong Kong chapter since 2010 and AO trustee from 2012 till 2017. He is now working as a consultant in the department and also an honorary clinical associate professor in the university. In 2018, he moved from the deputy chief of the Trauma division and take up the post of division chief in the Division of General Orthopaedics.

His first part of his professional career includes minimally invasive surgeries and the development of new techniques in fracture management. In the last decade, in view of the ageing population and the increasing demand for fractures associated with the elderly, much work was done for the osteoporotic fracture treatment and medical system for their management. The geriatric hip fracture critical clinical pathway was first set up under his leadership in Hong Kong in 2007. Being the clinical champion of this team, he led his team to receive the outstanding team award in the Hong Kong west cluster region in the year 2008 and 2010. The team also received the best poster presentation in the Hong Kong Hospital Authority Convention 2008. He also received the outstanding staff award in 2017 in Hong Kong west cluster.

Recently, he moved on from focusing mainly on trauma and fracture treatment to a more challenging field, musculoskeletal infection. A working group, including other professions like microbiologists, infection nursing specialist, community nurses, physiotherapists and occupational therapists, is formed aiming to improve the management of primary infection in soft tissue and bones as well as infective complications in hip fracture patients and other post-surgical complications.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)